RavenQuest BioMed (CNSX:RQB) Producing Consistent Cannabis at Low Cost

RavenQuest BioMed Inc's (CNSX:RQB) (OTCMKTS:RVVQF) (FRA:1IT) Mathieu McDonald joins Midas Letter to discuss the company's cannabis plant research at McGill University to produce consistent cannabis at a low cost. The agreement with McGill University studies methodologies behind cannabis plant stabilization and yield maximization. Mr. McDonald also discusses the company's Cannabis Biocare joint-venture, which will provide full funding for facility build-outs and the company's revolutionary Orbital Garden technologies globally. Initial production will focus upon the Balkans and European expansion into East Africa, West Africa and the Middle East. Discussing the company's growing technology in comparison to the industry standard green house growing operations, Mathieu McDonald stat "We fit 500 square foot of row space on that, using 65% less power, 90% less nutrients and dripping 0 water to waste."

************************

Check out our website:


************************

SUBSCRIBE to our YouTube:


SUBSCRIBE to our 2nd YouTube Channel - Midas Letter Clips:


SUBSCRIBE to our Newsletter:


Download Our Podcast on iTunes:


************************

Follow Us on Twitter:


Like Us on Instagram:


Like Us on Facebook:


************************

#WeedStocks
#MidasLetter

midas letter,midas letter live,economy,news,cannabis,investing,weed stocks,pot stocks,ravenquest,biomed,orbital gardens,mcgill,biocare,cnsx:rqb,